Marti Boss

463 total citations
26 papers, 306 citations indexed

About

Marti Boss is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Marti Boss has authored 26 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Marti Boss's work include Neuroendocrine Tumor Research Advances (11 papers), Pancreatic function and diabetes (8 papers) and Neuroblastoma Research and Treatments (6 papers). Marti Boss is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Pancreatic function and diabetes (8 papers) and Neuroblastoma Research and Treatments (6 papers). Marti Boss collaborates with scholars based in Netherlands, Switzerland and United States. Marti Boss's co-authors include Martin Gotthardt, Maarten Brom, Mijke Buitinga, Aleksey V. Matveyenko, Safia Costes, Anthony P. Thomas, Sanne A. M. van Lith, Martin Béhé, Eric P. Visser and Lieke Joosten and has published in prestigious journals such as Diabetes, Diabetologia and Molecules.

In The Last Decade

Marti Boss

24 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marti Boss Netherlands 10 109 100 90 76 58 26 306
Itaru Tsumanuma Japan 10 65 0.6× 30 0.3× 83 0.9× 49 0.6× 83 1.4× 18 359
Anna Gruszka Poland 12 83 0.8× 22 0.2× 168 1.9× 90 1.2× 21 0.4× 22 329
S Khalaf United Kingdom 8 76 0.7× 74 0.7× 135 1.5× 48 0.6× 123 2.1× 13 415
Arif Şanlı Türkiye 9 23 0.2× 54 0.5× 98 1.1× 96 1.3× 11 0.2× 32 350
Lucy Brazil United Kingdom 6 125 1.1× 30 0.3× 24 0.3× 75 1.0× 4 0.1× 13 274
Chun Jiang Yu China 7 83 0.8× 64 0.6× 72 0.8× 75 1.0× 5 0.1× 8 387
Michael J. Malone United States 12 33 0.3× 49 0.5× 86 1.0× 117 1.5× 10 0.2× 34 456
Xiao Zhu United States 9 24 0.2× 73 0.7× 33 0.4× 41 0.5× 5 0.1× 25 301
Matthias Dottermusch Germany 10 26 0.2× 53 0.5× 40 0.4× 41 0.5× 4 0.1× 27 327
F. Descos France 12 151 1.4× 99 1.0× 80 0.9× 436 5.7× 37 0.6× 26 779

Countries citing papers authored by Marti Boss

Since Specialization
Citations

This map shows the geographic impact of Marti Boss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marti Boss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marti Boss more than expected).

Fields of papers citing papers by Marti Boss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marti Boss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marti Boss. The network helps show where Marti Boss may publish in the future.

Co-authorship network of co-authors of Marti Boss

This figure shows the co-authorship network connecting the top 25 collaborators of Marti Boss. A scholar is included among the top collaborators of Marti Boss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marti Boss. Marti Boss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kühnen, Peter, K Rothe, Kathrin Hauptmann, et al.. (2025). [68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism. EJNMMI Research. 15(1). 107–107.
2.
Buitinga, Mijke, Sanne A. M. van Lith, Lieke Joosten, et al.. (2024). Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas. EJNMMI Research. 14(1). 96–96.
3.
Boss, Marti, Rick I. Meijer, Cathelijne Frielink, et al.. (2024). Activation of the HPA Axis Does Not Explain Nonresponsiveness to GLP-1R Agonist Treatment in Individuals With Type 2 Diabetes. Diabetes. 74(2). 212–222. 1 indexed citations
4.
Boss, Marti, Olle Eriksson, Annemarie Eek, et al.. (2023). Improved localization of insulinomas using 68Ga-NODAGA-exendin-4 PET/CT. Nuklearmedizin - NuclearMedicine. 62(2). 97–98. 4 indexed citations
5.
Hopman, Maria T. E., Marti Boss, Martin Gotthardt, et al.. (2023). Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia. American Journal of Physiology-Endocrinology and Metabolism. 324(3). E209–E216. 3 indexed citations
6.
Buitinga, Mijke, Marti Boss, Michiel F. Nijhoff, et al.. (2023). Monitoring β-Cell Survival After Intrahepatic Islet Transplantation Using Dynamic Exendin PET Imaging: A Proof-of-Concept Study in Individuals With Type 1 Diabetes. Diabetes. 72(7). 898–907. 6 indexed citations
7.
Boss, Marti, Martin Gotthardt, Giorgio Baldari, et al.. (2022). Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [68Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method. Molecules. 27(2). 543–543. 9 indexed citations
8.
Brom, Maarten, Marti Boss, Mijke Buitinga, et al.. (2022). Importance of beta cell mass for glycaemic control in people with type 1 diabetes. Diabetologia. 66(2). 367–375. 5 indexed citations
9.
Boss, Marti, et al.. (2022). Protocol for Clinical GLP-1 Receptor PET/CT Imaging with [68Ga]Ga-NODAGA-Exendin-4. Methods in molecular biology. 2592. 143–153. 6 indexed citations
10.
Boss, Marti, et al.. (2021). Proceedings of the World Molecular Imaging Congress 2021, October 5-8, 2021: Late-Breaking Abstracts. Molecular Imaging and Biology. 23(S2). 1739–2027. 3 indexed citations
11.
Boss, Marti, Christof Rottenburger, Winfried Brenner, et al.. (2021). 68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism. Journal of Nuclear Medicine. 63(2). 310–315. 18 indexed citations
12.
Boss, Marti, Irina Kusmartseva, Lieke Joosten, et al.. (2021). 111In-exendin SPECT imaging suggests presence of residual beta cells in patients with longstanding type 1 diabetes. Nuklearmedizin - NuclearMedicine. 1 indexed citations
13.
Deden, Laura N., Jan Booij, Joanes Grandjean, et al.. (2021). Brain Imaging of the GLP-1 Receptor in Obesity Using 68Ga-NODAGA-Exendin-4 PET. Brain Sciences. 11(12). 1647–1647. 9 indexed citations
14.
Boss, Marti, Desirée L. Bos, Cathelijne Frielink, et al.. (2020). Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions. Journal of Nuclear Medicine. 61(11). 1588–1593. 14 indexed citations
15.
Boss, Marti, Desirée L. Bos, Cathelijne Frielink, et al.. (2020). Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW. Journal of Nuclear Medicine. 61(7). 1066–1071. 8 indexed citations
16.
Boss, Marti, et al.. (2019). PET-Based Human Dosimetry of 68Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging. Journal of Nuclear Medicine. 61(1). 112–116. 27 indexed citations
17.
Buitinga, Mijke, Marti Boss, Eelco J.P. de Koning, et al.. (2019). Assessment of intrahepatic islet of Langerhans transplantation with dynamic Ga-68-NODAGA-exendin PET imaging. Nuklearmedizin - NuclearMedicine. 2 indexed citations
18.
Boss, Marti, Laura N. Deden, Maarten Brom, Sanne A. M. van Lith, & Martin Gotthardt. (2019). Pituitary GLP-1 receptor expression in the pathophysiology of type 2 diabetes. Nuklearmedizin - NuclearMedicine. 1 indexed citations
19.
Buitinga, Mijke, Marti Boss, Marcel Janssen, et al.. (2018). Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients. Journal of Nuclear Medicine. 60(6). 812–816. 23 indexed citations
20.
Boss, Marti, Mijke Buitinga, Maarten Brom, et al.. (2017). 68Ga-NODAGA-exendin-4 PET/CT for the Localization of Insulinomas: Preliminary Data from a Prospective Multicenter Imaging Study. 105. 165–165. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Itaru Tsumanuma Breakdown of academic impact, for papers by Anna Gruszka Breakdown of academic impact, for papers by S Khalaf Breakdown of academic impact, for papers by Arif Şanlı Breakdown of academic impact, for papers by Lucy Brazil Breakdown of academic impact, for papers by Chun Jiang Yu Breakdown of academic impact, for papers by Michael J. Malone Breakdown of academic impact, for papers by Xiao Zhu Breakdown of academic impact, for papers by Matthias Dottermusch Breakdown of academic impact, for papers by F. Descos
Rankless by CCL
2026